UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Summit X LLC

Summit X LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,849 shares of the healthcare conglomerate’s stock after selling 344 shares during the period. Summit X LLC’s holdings in UnitedHealth Group were worth $1,491,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Financial Management Professionals Inc. grew its stake in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after purchasing an additional 17 shares in the last quarter. Richwood Investment Advisors LLC grew its stake in shares of UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after purchasing an additional 20 shares in the last quarter. Global Wealth Strategies & Associates boosted its stake in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after buying an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC boosted its stake in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate’s stock valued at $1,080,000 after buying an additional 21 shares in the last quarter. Finally, Retirement Planning Group LLC boosted its stake in UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after buying an additional 21 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other news, CEO Stephen J. Hemsley acquired 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer directly owned 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director owned 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. 0.28% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on UNH shares. Barclays reduced their price objective on UnitedHealth Group from $350.00 to $337.00 and set an “overweight” rating for the company in a research note on Wednesday, July 9th. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective for the company. in a research note on Monday, May 19th. TD Securities reissued a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Finally, JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $405.00 to $418.00 and gave the stock an “overweight” rating in a research note on Friday, June 20th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $415.00.

UnitedHealth Group Price Performance

NYSE:UNH opened at $291.81 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock’s 50 day moving average price is $310.37 and its two-hundred day moving average price is $437.45. The firm has a market capitalization of $264.71 billion, a price-to-earnings ratio of 12.22, a P/E/G ratio of 1.44 and a beta of 0.45. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter last year, the business posted $6.91 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.03%. The ex-dividend date was Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is currently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.